Quarterly Report (10-q)

Date : 11/13/2018 @ 12:26PM
Source : Edgar (US Regulatory)
Stock : Remsleep Holdings, Inc. (PN) (RMSL)
Quote : 0.0246  0.0001 (0.41%) @ 9:06PM

Quarterly Report (10-q)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2018

 

Commission file number: 000-53450

 

REMSLEEP HOLDINGS, INC.

(Name of registrant as specified in its charter)

 

Nevada   47-5386867
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

637 N. Orange Ave, Suite 609, Orlando, FL 32789

(Address of principal executive offices) (Zip Code)

 

912-590-2001

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No .

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ . No ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Non-accelerated filer ☐

Emerging growth company ☐

Accelerated filer ☐

Smaller reporting company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ .

 

As of November 9, 2018, there were 6,025,894 shares of common stock outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

        Page No.
         
PART I. - FINANCIAL INFORMATION    
     
Item 1.   Financial Statements   1
         
Item 2.   Management’s Discussion and Analysis of Financial Condition and Plan of Operations   9
         
Item 3.   Quantitative and Qualitative Disclosures About Market Risk   12
       
Item 4   Controls and Procedures   12
         
PART II - OTHER INFORMATION    
     
Item 1.   Legal Proceedings   13
         
Item 1A.   Risk Factors   13
         
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds   13
         
Item 3.   Defaults Upon Senior Securities   13
         
Item 4.   Mine Safety Disclosures   13
         
Item 5.   Other Information   13
         
Item 6.   Exhibits   13
         
Signatures       14

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

REMSLEEP HOLDINGS, INC.

 

Condensed Balance Sheets as of September 30, 2018 (Unaudited) and December 31, 2017 (Audited)   2
     
Condensed Statements of Operations for the Three and Nine Months ended September 30, 2018 and 2017 (Unaudited)   3
     
Condensed Statements of Cash Flows for the Nine Months ended September 30, 2018 and 2017 (Unaudited)   4
     
Condensed Notes to Financial Statements (Unaudited)   5

 

1

 

 

REMSLEEP HOLDINGS, INC.

CONDENSED BALANCE SHEETS

 

 

   

September 30,

2018

   

December 31,

2017

 
ASSETS   (Unaudited)        
Current assets:            
Cash   $ 40,955     $ 2,014  
Prepaid expenses     11,983       173,282  
Total current assets     52,938       175,296  
Property and equipment, net     32,326       8,486  
                 
Total Assets   $ 85,264     $ 183,782  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT                
                 
Current Liabilities:                
Accounts payable   $ 244,398     $ 239,878  
Accrued compensation     350       2,850  
Accrued interest     15,710       12,341  
Accrued stock to be issued     -       194,068  
Convertible Notes, net of discount of $59,264     17,736       -  
Derivative Liability     130,915       -  
Loan payable – related party     179,191       182,191  
Loan payable     45,000       50,000  
                 
Total Liabilities     633,300       681,328  
                 
Commitments and Contingencies     -       -  
                 
STOCKHOLDERS’ DEFICIT:                
                 
Series A preferred stock, no par value, 5,000,000 shares authorized, 3,500,000 and 3,500,000 issued and outstanding, respectively     105,000       105,000  
Series B preferred stock, no par value, 5,000,000 shares authorized, no shares issued     -       -  
Series C preferred stock, no par value, 5,000,000 shares authorized, no shares issued     -       -  
Common stock, $.001 par value, 1,000,000,000 shares authorized, 6,025,894 and 3,610,751 shares issued and outstanding, respectively     6,026       3,611  
Common stock to be issued     228,604       58,225  
Additional paid in capital     1,020,307       424,938  
Accumulated Deficit     (1,907,973 )     (1,089,320 )
TOTAL STOCKHOLDERS’ DEFICIT     (548,036 )     (497,546 )
                 
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 85,264     $ 183,782  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

REMSLEEP HOLDINGS, INC.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

   

For the Three Months Ended

September 30,

   

For the Nine Months Ended

September 30,

 
    2018     2017     2018     2017  
          (Restated)           (Restated)  
Operating Expenses:                        
Professional fees   $ 5,650     $ 8,250     $ 41,750     $ 68,462  
Consulting     220,000       88,531       603,799       458,635  
Officer compensation     9,000       6,000       27,000       18,000  
General and administrative     8,289       6,637       21,990       21,281  
                                 
Total operating expenses     242,939       109,418       694,539       566,378  
                                 
Loss from operations     (242,939 )     (109,418 )     (694,539 )     (566,378 )
                                 
Other expenses:                                
Interest expense     (2,130 )     (630 )     (3,369 )     (1,869 )
Discount amortization     (14,936 )     -       (14,936 )     -  
Loss on issuance of convertible debt     (47,020 )     -       (47,020 )     -  
Change in fair value of derivative     (41,894 )     -       (58,789 )     -  
Total other expense     (105,980 )     (630 )     (124,114 )     (1,869 )
                                 
Loss before income taxes     (348,919 )     (110,048 )     (818,653 )     (568,247 )
                                 
Provision for income taxes     -       -       -       -  
                                 
Net Loss   $ (348,919 )   $ (110,048 )   $ (818,653 )   $ (568,247 )
                                 
Net loss per share, basic and diluted   $ (0.06 )   $ (0.03 )   $ (0.16 )   $ (0.17 )
                                 
Weighted average common shares outstanding, basic and diluted     5,970,460       3,448,795       5,144,683       3,289,506  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

REMSLEEP HOLDINGS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

   

For the Nine Months Ended

September 30,

 
    2018     2017  
          (Restated)  
Cash Flows from Operating Activities:                
Net loss   $ (818,653 )   $ (568,247 )
Adjustments to reconcile net loss to net cash used in operations:                
Depreciation expense     1,723       3,843  
Stock compensation expense     603,499       478,125  
Change in fair value of derivative     58,789       -  
Discount amortization     14,936       -  
Loss on issuance of convertible debt     47,020       -  
Changes in Operating Assets and Liabilities                
Prepaids     (2,200 )     -  
Accounts Payable     4,520       4,500  
Accrued officer compensation     (2,500 )     7,850  
Accrued interest     3,370       1,869  
Net cash used in operating activities     (89,496 )     (72,060 )
                 
Cash Flows from Investing Activities:                
Purchase of equipment     (25,563 )     -  
Net Cash used in investing activities     (25,563 )     -  
                 
Cash Flows from Financing Activities:                
Proceeds/repayments – related party     (3,000 )     72,115  
Repayment of loans     (5,000 )     -  
Proceeds from convertible notes payable     72,000       -  
Proceeds from sale of common stock     90,000       -  
Net cash provided by financing activities     154,000       72,115  
                 
Net increase in cash     38,941       55  
Cash at beginning of the period     2,014       -  
Cash at end of the period   $ 40,955     $ 55  
                 
Supplemental cash flow information:                
Interest paid in cash   $ -     $ -  
Taxes paid   $ -     $ -  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

REMSLEEP HOLDINGS, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

September 30, 2018

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Business Activity

 

REMSleep Holdings, Inc., (the “Company”) was incorporated in the State of Nevada on June 6, 2007. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea. On May 30, 2015 REMSleep LLC was formally merged into REMSleep Holdings, Inc.

 

Basis of Presentation

These unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in the Company’s 10-K for its fiscal year ended December 31, 2017. In the opinion of the Company, all adjustments, including normal recurring adjustments necessary to present fairly the financial position of the Company, as of September 30, 2018 and the results of its operations and cash flows for the nine-month periods then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year.

 

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

 

Reclassifications

Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the financial statements for the nine months ended September 30, 2018.

 

Fair Value of Financial Instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels.  The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

 

Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
   
Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
   
Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data.

 

The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximates the fair value of such instruments as the notes bear interest rates that are consistent with current market rates.

 

5

 

 

The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of:

 

September 30, 2018:

 

Description   Level 1     Level 2     Level 3     Total Gains and (Losses)  
Derivative   $ -     $ -     $ 130,915     $ (41,894 )

 

Derivative Financial Instruments

Derivative liabilities are recognized in the balance sheet at fair value based on the criteria specified in Financial Accounting Standards Board ( “FASB” ) Accounting Standards Codification ( “ASC” ) Topic 815-15 – Derivatives and Hedging – Embedded Derivatives ( “ASC 815-15” ). Pursuant to ASC Topic 815-15 an evaluation of the embedded conversion feature of convertible debt is evaluated to determine if the bifurcated debt conversion feature is required to be classified as a derivative liability. Since the terms of the embedded conversion features of the Company’s convertible debt provides for the issuance of shares of common stock at the election of the holders and the number of shares is subject to adjustment for a decline in the price of the Company’s common stock, the Company determined that the embedded conversion option met the criteria of a derivative liability. The estimated fair value of the embedded conversion feature of debt classified as derivative liabilities are determined using the Black-Scholes option pricing model. The model utilizes Level 3 unobservable inputs to calculate the fair value of the derivative liabilities at each reporting period.

 

The Company determined that using an alternative valuation model such as a Binomial-Lattice model would result in minimal differences. The fair value of the embedded conversion feature of debt classified as derivative liabilities are adjusted for changes in fair value at each reporting period, and the corresponding non-cash gain or loss is recorded as other income or expense in the statement of operations. As of September 30, 2018, the embedded conversion feature of $130,915 of convertible notes payable was classified as a derivative liability. Each reporting period the embedded conversion feature is re-valued and adjusted through the caption “change in fair value of derivative liabilities” on the statements of operations.

 

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements will cause a material impact on its financial condition or the results of its operations.

 

NOTE 2 - GOING CONCERN

 

The accompanying unaudited financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has an accumulated deficit of $1,907,973 at September 30, 2018, had a net loss of $818,653 and net cash used in operating activities of $89,496 for the nine months ended September 30, 2018. The Company’s ability to raise additional capital through the future issuances of common stock and/or debt financing is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. These conditions and the ability to successfully resolve these factors over the next twelve months raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

 

NOTE 3 - PROPERTY & EQUIPMENT

 

Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

 

Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets as follows between three and five years.

 

Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.

 

6

 

 

Assets stated at cost, less accumulated depreciation consisted of the following:

 

    September 30, 2018     December 31, 2017  
Equipment   $ 14,904     $ 14,904  
Office equipment     2,458       -  
Tooling / Molds     23,105       -  
Less: accumulated depreciation     (8,141 )     (6,418 )
Fixed assets, net   $ 32,326     $ 8,486  

 

Depreciation expense

 

Depreciation expense for the nine months ended September 30, 2018 and 2017 was $1,723 and $3,843, respectively. Depreciation expense for the three months ended September 30, 2018 and 2017 was $691 and $516, respectively.

 

NOTE 4 – LOAN PAYABLE

 

On October 24, 2017, the Company was notified that a petition had been filed in the Iowa District Court for Polk County by a Mr. John M. Wesson for failure to repay a loan. Mr. Wesson had loaned the Company $30,000 and $20,000 on October 24, 2012 and June 12, 2013, respectively. The loans were to accrue interest at 5%. While the Company was under previous management the loans were removed from the books in Q1 of 2015. On April 26, 2018, the Company agreed to repay the loan in full including accrued interest and $5,000 for legal fees. The $50,000 plus $7,341 was booked to retained earnings in 2016 as a correction of an error. As of September 30, 2018, $5,000 has been paid towards the amount due and there is $14,211 of interest accrued on the loan.

 

NOTE 5 – CONVERTIBLE NOTES

 

On July 9, 2018, the Company issued a Convertible Promissory Note in favor of Power Up Lending Group LTD (“Power Up”). The principal amount of the Note is $45,000 with an original issue discount of $3,000 and carries an interest rate of 12% per annum. It becomes due and payable with accrued interest on July 9, 2019. Power Up has the option to convert the Note plus accrued interest into common shares of the Company, after 180 days. The conversion rate is a 39% discount to the average of the lowest two trading price for twenty days prior to the date of conversion. The company bifurcated the conversion feature and accounted for it as a derivative liability. The Company recorded the derivative liability at its fair value of $89,020 based on the Black Scholes Merton pricing model and a corresponding debt discount of $42,000 to be amortized utilizing the interest method of accretion over the term of the note. As of September 30, 2018, the Company fair valued the derivative at $130,915. In addition, $10,233 of the debt discount has been amortized to interest expense.

 

A summary of the activity of the derivative liability for the notes above is as follows:

 

Balance at December 31, 2017   $ -  
Increase to derivative due to new issuances   $ 89,020  
Derivative loss due to mark to market adjustment   $ 41,895  
Balance at September 30, 2018   $ 130,915  

 

A summary of quantitative information about significant unobservable inputs (Level 3 inputs) used in measuring the Company’s derivative liability that are categorized within Level 3 of the fair value hierarchy for the nine months ended September 30, 2018 is as follows:

 

Inputs   September 30, 2018     Initial Valuation  
Stock price   $ .075     $ .55  
Conversion price   $ .0244     $ .244  
Volatility (annual)     375.66 %     261.04 %
Risk-free rate     2.47 %     2.34 %
Years to maturity     .77       1  

 

7

 

 

The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management

 

On August 30, 2018, the Company issued a Convertible Promissory Note in favor of LG Capital Funding LLC (“LG”). The principal amount of the Note is $32,000 with an original issue discount of $2,000 and carries an interest rate of 10% per annum. It becomes due and payable with accrued interest on August 30, 2019. During the first six months LG has the option to convert the Note plus accrued interest at a fixed price of $0.10 per share. After the 6-month anniversary, the Conversion Price shall be equal to 60% of the lowest closing bid price for the eighteen prior trading days including the day of conversion. The Company accounted for the initial conversion feature as a beneficial conversion feature. A beneficial conversion feature arises when the conversion price of a convertible instrument is below the per share fair value of the underlying stock into which it is convertible. If LG were to convert at the price of $.10 they could convert the full $32,000 into 320,000 shares of common stock. Using the stock price on the date the note was issued of $.185 and the conversion price of $.10, the Company valued each share at $.085 for an additional expense of $27,200. The Company has accounted for the $27,200 has debt discount with a credit to additional paid in capital. The discount will be amortized over the six months. As of September 30, 2018, $4,533 has been amortized to interest expense.

 

NOTE 6 - COMMON STOCK

 

On November 16, 2017, the Company issued, as compensation for services provided, 1,087,261 common shares with a fair value of $0.2125 per share for total non-cash expense of $231,043. The expense is being recognized over the six-month term of the contract. As of December 31, 2017, $57,761 has been debited to consulting expense. In addition, as of December 31, 2017, the shares have not yet been issued; as a result, $36,975 has been credited to common stock to be issued and the remaining $194,068 to accruals. As of September 30, 2018, the shares were re-valued at $0.231 for a change in value of $16,895. In addition, $173,282 was amortized to stock for services expense and the accrual for stock to be issued was reclassed to common stock to be issued in equity, which was reduced $40,584 for the issuance of 178,000 shares by the transfer agent. As of September 30, 2018, the full amount has been amortized to stock compensation expense.

 

During the nine months ended September 30, 2018, the Company sold 477,143 shares of common stock for total cash proceeds of $90,000.

 

During the nine months ended September 30, 2018, the Company granted 1,760,000 shares of common stock for services at $0.25 per share for total non-cash expense of $440,000 which is being amortized over the six-month term of the applicable service agreements. As of September 30, 2018, $430,217 has been amortized to consulting expense, for a balance of $9,783.

 

NOTE 7 - PREFERRED STOCK

 

The Company is currently authorized to issue 5,000,000 Class A preferred shares, $0.001 per value with 1:25 voting rights.

 

On February 25, 2016, the Company issued 2,000,000 Class A preferred shares. On April 26, 2016 the Company issued 1,500,000 Class A preferred shares. The fair value of the shares was based on the price quoted on the OTC pink sheets on the grant date for the common shares as the preferred shares have a preference of a 1 to 1 conversion to common stock. The Company recognized compensation expense to its officers. As of September 30, 2018, there are 3,500,000 Class A Preferred shares outstanding.

 

NOTE 8 - RELATED PARTY TRANSACTIONS

 

The Company has received support from parties related through common ownership and directorship. These loans are unsecured, non-interest bearing and due on demand. As of September 30, 2018, and December 31, 2017, the balance due on these loans is $179,191 and $182,191, respectively.

 

NOTE 9 – RESTATEMENT

 

The September 30, 2017 financial statements are being restated to revise the accounting for retroactive adjustments for stock compensation and other general and administrative expenses identified during the year ended December 31, 2017 audit.

 

The following table summarizes changes made to the nine months ended September 30, 2017 Statement of Operations.

 

    For the nine months ended
September 30, 2017
 
    As Reported     Adjustment     As Restated  
Operating expenses                        
Professional fees   $ (56,662 )   $ (11,800 )   $ (68,462 )
Consulting     (113,560 )     (345,075 )     (458,635 )
Officer compensation     (10,000 )     (8,000 )     (18,000 )
General and administrative     (21,236 )     (45 )     (21,281 )
Other expense                        
Interest expense     -       (1,869 )     (1,869 )
Net Loss   $ (201,458 )   $ (366,789 )   $ (568,247 )

 

NOTE 10 - SUBSEQUENT EVENTS

 

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

 

8

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS.

 

Forward-looking Statements

 

There are “forward-looking statements” contained in this quarterly report. All statements that express expectations, estimates, forecasts or projections are forward-looking statements. In addition, other written or oral statements which constitute forward-looking statements may be made by us or on our behalf. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “project,” “forecast,” “may,” “should,” variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in or suggested by such forward-looking statements. We undertake no obligation to update or revise any of the forward-looking statements after the date of this quarterly report to conform forward-looking statements to actual results. Important factors on which such statements are based are assumptions concerning uncertainties, including but not limited to, uncertainties associated with the following:

 

Inadequate capital and barriers to raising the additional capital or to obtaining the financing needed to implement our business plans;
Our failure to earn revenues or profits;
Inadequate capital to continue business;
Volatility or decline of our stock price;
Potential fluctuation in quarterly results;
Rapid and significant changes in markets;
Litigation with or legal claims and allegations by outside parties; and
Insufficient revenues to cover operating costs.

 

The following discussion should be read in conjunction with the financial statements and the notes thereto which are included in this quarterly report. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ substantially from those anticipated in any forward-looking statements included in this discussion as a result of various factors.

 

Overview

 

We were incorporated in the State of Nevada on June 6, 2007. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea.

 

Our officers have 35 years of sleep-industry experience, including working at sleep industry companies. Our officers invented our DeltaWave CPAP (continuous positive airway pressure) interface (the “DeltaWave”). We have developed the DeltaWave as an innovative new device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillows type interface designed to result in better comfort and, therefore, better compliance. The Delta Wave is specifically designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. A survey that appeared in DME Business found that 89% of patients stated that mask-interface comfort was their primary concern. The primary issue that we have addressed with the DeltaWave is the “work of breathing” component. We believe that our DeltaWave is designed to effectively address the stubborn issues that continue to affect a patient’s ability to comply with treatment, as follows:

 

Does not disrupt normal breathing mechanics;
Is not claustrophobic;
Causes zero work of breathing (WOB);
Minimizes or eliminates drying of the sinuses;
Uses less driving pressure; and
Allows users to feel safe and secure while sleeping.

 

We plan to conduct clinical trials to test product effectiveness.

 

Our goal is to develop sleep products that achieve optimum compliance and comfort for CPAP patients.

 

On June 28, 2016, we applied for a patent for a new, innovative sleep apnea product that serves as an interface for the delivery of CPAP therapy and other respiratory needs. This patent is still pending.

 

Our website is located at: http://www.remsleeptech.com.

 

9

 

 

Results of Operations

 

The three months ended September 30, 2018 compared to the three months ended September 30, 2017

 

Professional fees were $5,650 compared to $8,250 for the three months ended September 30, 2018 and 2017, respectively, a decrease of $2,600, or 31.5%. Professional fees consist mostly of accounting, audit and legal fees. The decrease in the current period is due to lower legal and audit expense.

 

Consulting expense was $220,000 compared to $88,531 for the three months ended September 30, 2018 and 2017, respectively, an increase of $131,469, or 148.5%. In the current period we recognized $220,000 of non-cash stock compensation expense. In the previous period we issued 400,000 shares of common stock to consultants for total non-cash expense of $85,000.

 

Officer compensation was $9,000 and $6,000 for the three months ended September 30, 2018 and 2017, respectively, an increase of $3,000. The increase is due to an increase in monthly compensation to our CEO.

 

General and administrative expense was $8,289 and $6,637 for the three months ended September 30, 2018 and 2017, respectively, an increase of $1,652, or 24.8%.

 

Total other expense for the three months ended September 30, 2018, was $105,980. Other expense includes $14,936 of debt discount amortization, a $47,020 loss on the issuance of convertible debt and a loss in the change of fair value of $41,894. These are all new expenses related to newly issued convertible debt. We also had $2,130 of interest expense compared to $630 in the prior period.

 

Net Loss

For the three months ended September 30, 2018, we had a net loss of $348,919 as compared to a net loss of $110,048 for the three months ended September 30, 2017. Our net loss was higher in the current period primarily due to the expense associated with issuing stock for services and the other non-cash expense from the issuance of convertible debt.

 

The nine months ended September 30, 2018 compared to the nine months ended September 30, 2017

 

Professional fees were $41,750 and $68,462 for the nine months ended September 30, 2018 and 2017, respectively, a decrease of $26,712 or 39.0%. Professional fees consist mostly of accounting, audit and legal fees. The decrease of $26,712 in the current period is attributed to lower legal and audit fees.

 

Consulting expense was $603,799 and $458,635 for the nine months ended September 30, 2018 and 2017, respectively. In the current period we recognized $603,499 of non-cash stock compensation expense compared to $455,104 of non-cash stock compensation expense in the prior period.

 

Officer compensation was $27,000 and $18,000 for the nine months ended September 30, 2018 and 2017, respectively, an increase of $9,000. The increase is due to an increase in monthly compensation to our CEO.

 

General and administrative expense was $21,990 and $21,281 for the nine months ended September 30, 2018 and 2017, respectively, an increase of $709.

 

Total other expense for the nine months ended September 30, 2018, was $124,114. Other expense includes $14,936 of debt discount amortization, a $47,020 loss on the issuance of convertible debt and a loss in the change of fair value of $58,789. These are mostly new expenses related to newly issued convertible debt. We also had $3,369 of interest expense compared to $1,869 in the prior period.

 

10

 

 

Net Loss

For the nine months ended September 30, 2018, we had a net loss of $818,653 as compared to a net loss of $568,247 for the nine months ended September 30, 2017. Our net loss was higher in the current period primarily due to the expense associated with issuing stock for services and the other non-cash expense from the issuance of convertible debt.

 

Going Concern

 

As of September 30, 2018, there is substantial doubt regarding our ability to continue as a going concern as we have not generated sufficient cash flow to fund our proposed business.

 

We have suffered recurring losses from operations since our inception. In addition, we have yet to generate an internal cash flow from our business operations or successfully raised the financing required to develop our proposed business. As a result of these and other factors, our independent auditor has expressed substantial doubt about our ability to continue as a going concern. Our future success and viability, therefore, are dependent upon our ability to generate capital financing. The failure to generate sufficient revenues or raise additional capital may have a material and adverse effect upon us and our shareholders.

 

Management’s plans with regard to these matters encompass the following actions: (i) obtaining funding from new investors to alleviate our working capital deficiency, and (ii) implementing a plan to generate sales. Our continued existence is dependent upon our ability to resolve our liquidity problems and increase profitability in our current business operations. However, the outcome of management’s plans cannot be ascertained with any degree of certainty. Our financial statements do not include any adjustments that might result from the outcome of these risks and uncertainties.

 

Liquidity and Capital Resources

 

Cash flow from operations

Cash used in operating activities for the nine months ended September 30, 2018 was $89,496 as compared to $72,060 cash used in operating activities for the same period ended 2017.

 

Cash Flows from Investing

Cash used in investing activities for the nine months ended September 30, 2018 was $25,563 as compared to $0 of cash used in investing activities for the same period ended 2017.

 

Cash Flows from Financing

For the nine months ended September 30, 2018, we received $72,000 from the issuance of convertible debt, $90,000 from the sale of common stock and repaid $8,000 of loans. For the nine months ended September 30, 2017, we received $72,115 that was advanced from the Chairman to pay for operating expenses.

 

Off Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes.  Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

 

We are subject to various loss contingencies arising in the ordinary course of business.  We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies.  An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired, or a liability has been incurred and the amount of the loss can be reasonably estimated.  We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

 

11

 

 

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities.  The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled.  Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

 

Recent Accounting Pronouncements

 

We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe that any future adoption of such pronouncements will have a material impact on our financial condition or the results of our operations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not Applicable

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Each of our principal executive and principal financial officer has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a - 15(e) and 15d - 15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on their evaluation, each such person concluded that our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting as of September 30, 2018. Such material weaknesses include a lack of segregation of duties and timely and accurate reconciliation of accounts.

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

 

Changes in Internal Control over Financial Reporting.

 

Our management has evaluated whether any change in our internal control over financial reporting occurred during the last fiscal quarter. Based on that evaluation, management concluded that there has been no change in our internal control over financial reporting during the relevant period that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

12

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the nine months ended September 30, 2018, the Company sold 477,143 shares of common stock for total cash proceeds of $90,000. All proceeds were used for general operating expenses.

 

During the nine months ended September 30, 2018, the Company granted 1,760,000 shares of common stock for services at $0.25 per share for total non-cash expense of $440,000 which is being amortized over the six-month term of the applicable service agreements. As of September 30, 2018, $430,217 has been amortized to consulting expense.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

On July 26, 2018, Michael Gillespie & Associates, PLLC (“Gillespie”) was dismissed as the registrant’s independent registered public accountant.  

 

On July 26, 2018, the registrant engaged Fruci & Associates II, PLLC (“Fruci”) as its new independent registered public accountant.

 

ITEM 6. EXHIBITS

 

(a) Documents furnished as exhibits hereto:

 

Exhibit No.   Description
     
31.1   Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Calculation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Label Linkbase Document
     
101.PRE   XBRL Taxonomy Presentation Linkbase Document

 

13

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  REMSLEEP HOLDINGS CORP.
     
Date: November 13, 2018 By:   /s/ Tom Wood
    Tom Wood
   

Chief Executive Officer/

Principal Financial Officer/Director

 

 

14

 

 

RemSleep Holdings, Inc. (USOTC:RMSL)
Historical Stock Chart

1 Year : From Aug 2018 to Aug 2019

Click Here for more RemSleep Holdings, Inc. Charts.

RemSleep Holdings, Inc. (USOTC:RMSL)
Intraday Stock Chart

Today : Friday 23 August 2019

Click Here for more RemSleep Holdings, Inc. Charts.

Latest RMSL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.